Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas

14Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Background: Although lymph node metastasis is a poor prognostic factor in patients with pancreatic ductal adenocarcinoma (PDAC), our understanding of lymph node size in association with PDAC is limited. Increased nodal size in preoperative imaging has been used to detect node metastasis. We evaluated whether lymph node size can be used as a surrogate preoperative marker of lymph node metastasis. Methods: We assessed nodal size and compared it to the nodal metastatic status of 200 patients with surgically resected PDAC. The size of all lymph nodes and metastatic nodal foci were measured along the long and short axis, and the relationships between nodal size and metastatic status were compared at six cutoff points. Results: A total of 4,525 lymph nodes were examined, 9.1% of which were metastatic. The mean size of the metastatic nodes (long axis, 6.9±5.0 mm; short axis, 4.3±3.1 mm) was significantly larger than that of the non-metastatic nodes (long axis, 5.0±4.0 mm; short axis, 3.0±2.0 mm; all p

Cite

CITATION STYLE

APA

Shin, J., Shin, S., Lee, J. H., Song, K. B., Hwang, D. W., Kim, H. J., … Hong, S. M. (2020). Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas. Journal of Pathology and Translational Medicine, 54(5), 387–395. https://doi.org/10.4132/jptm.2020.06.23

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free